Literature DB >> 31515819

In vitro propagation of tilapia lake virus in cell lines developed from Oreochromis mossambicus.

Ravi Nanthini1, Seepoo Abdul Majeed1, Sugumar Vimal1, Gani Taju1, Selvam Sivakumar1, Shanmugam Santhosh Kumar1, Devika Pillai2, Kalasseril Girijan Sneha2, Chakalaparambil Gokulan Rakesh2, Azeez Sait Sahul Hameed1.   

Abstract

Tilapia lake virus (TiLV)-suspected samples of tilapia were collected from grow-out ponds located with clinical signs and mortality ranged from 5% to 50%. The reverse transcription-polymerase chain reaction (RT-PCR) assay revealed the presence of TiLV in the disease outbreak ponds. Cell lines were developed from heart, gill and eye of Mozambique tilapia and characterized. Morphologically, these cell lines are composed of epithelioid cells. The optimum growth of these cells was observed at 28°C and 20% concentration of FBS. After cryopreservation, 70%-90% of cells were found to be viable. The cells of all three cell lines were found to be positive to fibronectin and pancytokeratin. PCR amplification of 16S rRNA and COI of O. mossambicus confirmed the origin of these cell lines from O. mossambicus. Heart and gill cell lines were found to be highly susceptible to TiLV and found to be useful for its isolation from infected fish samples. The experimental infection was carried out in O. niloticus and O. mossambicus using the TiLV propagated in susceptible cell lines. The RT-PCR results revealed the presence of TiLV in brain, gill, liver, kidney, spleen, eye, muscle, intestine and heart of experimentally infected O. niloticus and O. mossambicus.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  Tilapia lake virus; cell lines; experimental pathogenicity; tissue tropism; virus isolation

Mesh:

Year:  2019        PMID: 31515819     DOI: 10.1111/jfd.13075

Source DB:  PubMed          Journal:  J Fish Dis        ISSN: 0140-7775            Impact factor:   2.767


  4 in total

1.  Cell Culture-Derived Tilapia Lake Virus-Inactivated Vaccine Containing Montanide Adjuvant Provides High Protection against Viral Challenge for Tilapia.

Authors:  Weiwei Zeng; Yingying Wang; Huzi Hu; Qing Wang; Sven M Bergmann; Yahui Wang; Bo Li; Yuefeng Lv; Hua Li; Jiyuan Yin; Yingying Li
Journal:  Vaccines (Basel)       Date:  2021-01-25

2.  Combining segments 9 and 10 in DNA and recombinant protein vaccines conferred superior protection against tilapia lake virus in hybrid red tilapia (oreochromis sp.) compared to single segment vaccines.

Authors:  Pitakthai Chamtim; Eukote Suwan; Ha Thanh Dong; Soranuth Sirisuay; Nontawith Areechon; Eakapol Wangkahart; Ikuo Hirono; Rapeepat Mavichak; Sasimanas Unajak
Journal:  Front Immunol       Date:  2022-07-25       Impact factor: 8.786

3.  Infection of Tilapia tilapinevirus in Mozambique Tilapia (Oreochromis mossambicus), a Globally Vulnerable Fish Species.

Authors:  Pitchaporn Waiyamitra; Chutchai Piewbang; Somporn Techangamsuwan; Woei Chang Liew; Win Surachetpong
Journal:  Viruses       Date:  2021-06-09       Impact factor: 5.048

4.  Antiviral Activity of Ribavirin against Tilapia tilapinevirus in Fish Cells.

Authors:  Tuchakorn Lertwanakarn; Pirada Trongwongsa; Sangchai Yingsakmongkol; Matepiya Khemthong; Puntanat Tattiyapong; Win Surachetpong
Journal:  Pathogens       Date:  2021-12-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.